REDUCEDT+30Aquestive Therapeutics Inc · NASDAQ−25,000 sh · $120.5KFiled 16 Sept 2026·SEC Form 4·view source
ACQUIREDStaleAquestive Therapeutics Inc · NASDAQ+91,743 sh · $88.1KFiled 9 Sept 2026·SEC Form 4·view source